Current Clinical Practice in the Management of Atrial Fibrillation in Greece: the MANAGE-AF Study

Hellenic Cardiovascular Research Society603 enrolled

Overview

This is a multicenter, 1-year prospective, observational study of Atrial Fibrillation (AF) in Greece, designed to provide real world data regarding the characteristics of AF patients in Greece, as well as current clinical practices and adherence to the 2010 ESC guidelines.

Study Type

OBSERVATIONAL

Enrollment

603

Conditions

Atrial Fibrillation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients aged ≥ 18 years with any type of AF(first diagnosed, paroxysmal, persistent, long-standing persistent and permanent) according to the classification described in the recent ESC guidelines. 2. All patients should give written informed consent to participate in the study. Exclusion Criteria: 1. Patients anticipated life expectancy less than 1 year due to a severe concomitant disease. 2. Participation in an another clinical trial, with the exception of epidemiology trials (observational) that do not influence AF management. 3. Patients with mental disability unable to comply with follow - up visits and these who are unable to provide, in written, their informed consent or patients with anticipated inability to adhere to scheduled follow up visits.

Locations (27)

University Hospital of Alexandroupoli

Alexandroupoli, Greece

Outcomes

Primary Outcomes

Evaluation of the management of patients with Atrial Fibrillation.

Evaluation of the use of anticoagulants and antithrombotic drugs. Evaluation of the doctors' compliance with the guidelines.

Time frame: 1 year

Secondary Outcomes

Evaluation of the risk of strokes.

Evaluation of the risk in a large number of patients using the CHA2DS2-VASc and HAS-BLED scores.

Time frame: Baseline-6month-12months

Assessment of morbidity and mortality of patients with AF.

Assessment of morbidity and mortality of patients with AFduring one year follow-up in comparison with previous results from other registries.

Time frame: 1 year

Assessment of the compliance of patients to treatment.

Evaluation of the compliance of patients to treatment and the frequency of visits to their physician especially in terms of achieving therapeutic target INR (TTR, Time in Therapeutic Range).

Time frame: Baseline-6months-12months

Assessment of the awareness of patients about the Atrial Fibrillation.

Assessment of the awareness of patients about the Atrial Fibrilation and the potential risk of AF.

Time frame: Baseline

Assessment of patients' quality of life.

Assessment of patients' quality of life (QoL) using a specific questionnaire (EQ - 5D, http://www.euroqol.org) and EHRA score for evaluation of symptoms.

Time frame: Baseline-6months-12months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.